(Q41890123)

13 October 2017

TAK1-dependent autophagy: A suppressor of fatty liver disease and hepatic oncogenesis (English)

1 reference

13 October 2017

0 references

1 reference

Ekihiro Seki

1

1 reference

13 October 2017

language of work or name

1 reference

31 December 2014

1 reference

Molecular & cellular oncology

13 October 2017

1 reference

13 October 2017

1

1 reference

13 October 2017

4

1 reference

TAK1-mediated autophagy and fatty acid oxidation prevent hepatosteatosis and tumorigenesis

13 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4687902

TAK1 regulates hepatic cell survival and carcinogenesis

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4687902

Phosphorylation of p62 activates the Keap1-Nrf2 pathway during selective autophagy

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4687902

TAK1 regulates autophagic cell death by suppressing the phosphorylation of p70 S6 kinase 1.

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4687902

mTORC1 controls fasting-induced ketogenesis and its modulation by ageing.

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4687902

Disruption of TAK1 in hepatocytes causes hepatic injury, inflammation, fibrosis, and carcinogenesis

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4687902

The IKK complex contributes to the induction of autophagy

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4687902

TAK1 activates AMPK-dependent cytoprotective autophagy in TRAIL-treated epithelial cells.

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4687902

TAK1 suppresses a NEMO-dependent but NF-kappaB-independent pathway to liver cancer.

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4687902

10.4161/23723548.2014.968507

18 August 2018

Identifiers

DOI

0 references

1 reference

13 October 2017

PubMed publication ID

26709386

1 reference